Trueblood Wealth Management’s Amphenol APH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.65M Buy
15,040
+257
+2% +$37K 0.93% 18
2026
Q1
$1.87M Buy
14,783
+173
+1% +$24.4K 0.73% 31
2025
Q4
$1.97M Buy
14,610
+644
+5% +$86.1K 0.77% 30
2025
Q3
$1.73M Sell
13,966
-580
-4% -$63.6K 0.67% 33
2025
Q2
$1.44M Buy
14,546
+1,356
+10% +$111K 0.6% 49
2025
Q1
$865K Buy
13,190
+4,306
+48% +$294K 0.4% 87
2024
Q4
$617K Buy
8,884
+2,729
+44% +$191K 0.3% 114
2024
Q3
$401K Buy
6,155
+829
+16% +$53.7K 0.2% 145
2024
Q2
$359K Buy
5,326
+748
+16% +$47.2K 0.2% 142
2024
Q1
$264K Buy
+4,578
New +$240K 0.15% 176

Other funds holding APH

Trueblood Wealth Management's APH Position: Q2 2026 in Review

Trueblood Wealth Management increased its Amphenol (APH) stake by 1.7% in Q2 2026, buying an estimated $37K and bringing the position to 15,040 shares worth $2.65M. The position accounts for 0.93% of the portfolio, ranked #18.

Trueblood Wealth Management first reported a position in APH in Q1 2024 and has held it in 10 quarters since. 2,315 funds tracked by Wall St. Rank hold APH as of Q2 2026.

  • Trueblood Wealth Management held 15,040 shares of Amphenol worth $2.65M as of Q2 2026.
  • Trueblood Wealth Management bought 257 Amphenol shares in Q2 2026, an estimated $37K.
  • Amphenol made up 0.93% of Trueblood Wealth Management's portfolio in Q2 2026, its #18 holding.
  • Trueblood Wealth Management first reported a position in Amphenol in Q1 2024 and has held it in 10 quarters since.
  • 2,315 funds tracked by Wall St. Rank held Amphenol as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.